+91 7986995600
seclislabs@gmail.com
Contact Us
Antimicrobials: Antibiotics, Antivirals, AntiProtozoals, Antiparasitics

ZOCITH™ 500

Azithromycin 500 mg

Dosage Form Tablets
Packing 10*5 BLI
MRP Max DPCO
Prescribed By Pulmonologist, ENT Specialist, Dermatologist, General Physician, Internal Medicine

Quick Facts

Half Life 68 hours (tissue); Storage: Below 30°C; Schedule: H; DPCO: Yes; Pack: 10×5 BLI (50 tablets); Route: Oral tablet

Key Benefits

01
Highest-dose oral azithromycin — 500mg once daily for 3 days achieves equivalent efficacy to 5-day 250mg course through tissue depot
02
Pneumonia step-down — enables early discharge from hospital with equivalent drug exposure to IV azithromycin
03
DPCO-regulated — accessible pricing for community-acquired pneumonia outpatient management
04
10×5 pack — perfectly matches 5-day once-daily course
05
Atypical pathogen cover — Mycoplasma and Chlamydia coverage essential for empirical pneumonia management

Mechanism of Action

Azithromycin 500mg tablet — same 50S ribosomal binding mechanism. The 500mg tablet enables once-daily dosing as the loading dose or as the simplest possible regimen: 500mg once daily for 3 days — achieving equivalent tissue drug exposure to the 5-day 250mg course through azithromycin's 68-hour tissue half-life.

Indications

Adult community-acquired pneumonia (primary indication — 500mg once daily for 3–5 days), COPD exacerbations with atypical pathogen suspicion, moderate skin infections, and as step-down oral therapy from IV azithromycin in hospitalised patients. The 10×5 blister matches the 5-day once-daily course exactly.

Dosage & Administration

Dosage and administration should be as prescribed by a qualified doctor or medical professional. Do not self-medicate. Always follow your physician's instructions regarding dose, frequency and duration of treatment.

Why ZOCITH™ 500?

ZOCITH™ 500 is the pulmonologist's choice for outpatient community-acquired pneumonia and COPD exacerbation management. The 500mg once-daily regimen is the simplest possible antibiotic course — one tablet per day for three days — maximising compliance in patients who are often symptomatic and elderly. The DPCO regulation ensures this critical respiratory antibiotic remains accessible at point of care.

Interested in franchising ZOCITH™ 500?

Get exclusive monopoly rights in your territory. WHO-GMP certified. Pan India coverage with dedicated support.

📢

Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.

Scroll to Top